MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Measuring functional cognition with the Short Weekly Calendar Planning Activity in patients with Parkinson’s disease and non-manifesting LRRK2 and GBA carriers

    T. Schejter Margalit, N. Ben Binyamin, A. Thaler, I. Maidan, J. Cederbaum, A. Orr-Urtreger, M. Gana Weisz, O. Goldstein, N. Giladi, A. Mirelman, R. Kizony (Tel Aviv, Israel)

    Objective: The aims of this study were to explore the feasibility of the short Weekly Calendar Planning Activity (WCPA-10) to investigate functional cognition in patients…
  • 2022 International Congress

    Impact of two different rechargeable pulse generators on parkinsonian patients with deep brain stimulation

    C. Bogaert, C. Der Linden (Gent, Belgium)

    Objective: This study compared the recharging frequency and duration, perceived impact and self-management of recharging, and motor symptom suppression in fifteen PD patients who underwent…
  • 2022 International Congress

    MRI biomarkers of freezing of gait development in in Parkinson’s disease

    E. Sarasso, S. Basaia, C. Cividini, T. Stojkovic, I. Stankovic, N. Piramide, A. Tomic, V. Markovic, E. Stefanova, VS. Kostic, M. Filippi, F. Agosta (Milano, Italy)

    Objective: This study investigated longitudinal clinical, structural and functional brain alterations in Parkinson’s disease patients with freezing of gait (PD-FoG) and in those developing (PD-FoG-converters)…
  • 2022 International Congress

    Motor-Related and Cognition-Related Safety of Pimavanserin in Patients with Parkinson’s Disease Psychosis (PDP)

    V. Abler, C. Ballard, A. Berrio, B. Coate, C. Brain, A. Espay (San Diego, USA)

    Objective: Evaluate motor- and cognition-related safety in pimavanserin-treated patients with PDP. Background: Pimavanserin, a selective 5-HT2A inverse agonist/antagonist, is the only US FDA-approved treatment for…
  • 2022 International Congress

    Paliperidone induced neuroleptic malignant syndrome treated with electroconvulsive therapy and continuous apomorphine: A case report

    M. Gultekin, S. Benli (Kayseri, Turkey)

    Objective: Neuroleptic malignant syndrome (NMS) is a neurological emergency that is often induced by antipsychotic drugs. NMS may be mortal if left untreated. Background: In…
  • 2022 International Congress

    BIOMARKERS OF PARKINSONISM AND POSSIBILITIES OF PREDICTION OF THE COURSE OF PARKINSON’S DISEASE

    D. Akramova, K. Daminova (Tashkent, Uzbekistan)

    Objective: Parkinsonism is one of the most significant problems in clinical neurology, both due to its high prevalence in the world's populations and due to…
  • 2022 International Congress

    Continuous subcutaneous apomorphine infusion for the management of Parkinson’s disease at the end-of-life

    M. Bereau, M. Giffard, AL. Clairet, M. Verin, M. Auffret (Besançon, France)

    Objective: To describe the benefit of continuous subcutaneous apomorphine infusion (CSAI) for terminal care management in 7 PD patients. Background: There are currently no recommendations…
  • 2022 International Congress

    Adrenergic blockers and statins are associated with later age of onset in Parkinson’s disease

    C. Malatt, I. Khatiwala, M. Rangwala, A. Maleki, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)

    Objective: To evaluate the association of anti-hypertensives, non-steroidal anti-inflammatories (NSAIDs), statins, diabetes medications, smoking and family history of idiopathic Parkinson’s disease (iPD) with age of…
  • 2022 International Congress

    Analysis of somatosensory temporal discrimination in essential tremor treated with HIFU VIM thalamotomy: tremoric and lesional effects on the STDT

    CM. Ordás, F. Alonso-Frech, R. Martínez-Fernández, M. Del álamo, JA. Obeso (Móstoles, Spain)

    Objective: To compare somatosensory temporal discrimination threshold (STDT) previously and 4 months after unilateral (left) high intensity focused ultrasound (HIFU) thalamotomy. Secondly, to observe the…
  • 2022 International Congress

    Phase-amplitude coupling between beta power and high frequency oscillations as a sensitive marker of parkinsonian state.

    M. Bočková, M. Lamoš, P. Daniel, M. Baláž, J. Chrastina, I. říha, I. Rektor (Brno, Czech Republic)

    Objective: The aim of this work was to study the potential clinical usefulness of the phase-amplitude coupling (PAC) between beta power and high frequency oscillations (HFO´s).…
  • « Previous Page
  • 1
  • …
  • 631
  • 632
  • 633
  • 634
  • 635
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley